HK1057549A1 - Heteroaryl derivatives and the use thereof as pharmaceuticals - Google Patents

Heteroaryl derivatives and the use thereof as pharmaceuticals

Info

Publication number
HK1057549A1
HK1057549A1 HK04100290A HK04100290A HK1057549A1 HK 1057549 A1 HK1057549 A1 HK 1057549A1 HK 04100290 A HK04100290 A HK 04100290A HK 04100290 A HK04100290 A HK 04100290A HK 1057549 A1 HK1057549 A1 HK 1057549A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceuticals
heteroaryl derivatives
heteroaryl
derivatives
Prior art date
Application number
HK04100290A
Other languages
English (en)
Inventor
Peter Emig
Eckhard Guenther
Bernd Nickel
Silke Baasner
Gerald Bacher
Thomas Beckers
Beate Aue
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of HK1057549A1 publication Critical patent/HK1057549A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK04100290A 2000-07-21 2004-01-15 Heteroaryl derivatives and the use thereof as pharmaceuticals HK1057549A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035927A DE10035927A1 (de) 2000-07-21 2000-07-21 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
PCT/EP2001/008263 WO2002008194A1 (de) 2000-07-21 2001-07-18 Acridin-derivate und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
HK1057549A1 true HK1057549A1 (en) 2004-04-08

Family

ID=7649979

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100290A HK1057549A1 (en) 2000-07-21 2004-01-15 Heteroaryl derivatives and the use thereof as pharmaceuticals

Country Status (29)

Country Link
US (1) US6706722B2 (cs)
EP (1) EP1301485B1 (cs)
JP (1) JP2004504382A (cs)
KR (1) KR20030022296A (cs)
CN (1) CN1296359C (cs)
AR (1) AR033383A1 (cs)
AT (1) ATE365717T1 (cs)
AU (2) AU8967501A (cs)
BG (1) BG107507A (cs)
BR (1) BR0112591A (cs)
CA (1) CA2353360A1 (cs)
CY (1) CY1106890T1 (cs)
CZ (1) CZ2003427A3 (cs)
DE (2) DE10035927A1 (cs)
DK (1) DK1301485T3 (cs)
ES (1) ES2291349T3 (cs)
HK (1) HK1057549A1 (cs)
HU (1) HUP0303729A3 (cs)
IL (1) IL153476A0 (cs)
MX (1) MXPA02012564A (cs)
NO (1) NO324939B1 (cs)
NZ (1) NZ524155A (cs)
PL (1) PL358808A1 (cs)
PT (1) PT1301485E (cs)
RU (1) RU2267488C2 (cs)
SK (1) SK1932003A3 (cs)
UA (1) UA75085C2 (cs)
WO (1) WO2002008194A1 (cs)
ZA (1) ZA200210411B (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
AU2003246571B2 (en) * 2002-06-29 2008-06-26 Zentaris Gmbh Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
WO2004007470A1 (de) * 2002-07-17 2004-01-22 Zentaris Gmbh Neue anthracen-derivate und deren verwendung als arzneimittel
US7125461B2 (en) * 2003-05-07 2006-10-24 L & L Products, Inc. Activatable material for sealing, baffling or reinforcing and method of forming same
AR044586A1 (es) * 2003-06-04 2005-09-21 Aventis Pharma Sa Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion
FR2855825B1 (fr) * 2003-06-04 2008-08-22 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
US7249415B2 (en) * 2003-06-26 2007-07-31 Zephyros, Inc. Method of forming members for sealing or baffling
DE10331500A1 (de) * 2003-07-11 2005-02-24 Zentaris Gmbh Neue Acridin-Derivate und deren Verwendung als Arzneimittel
JP2008528573A (ja) * 2005-01-27 2008-07-31 アルマ マテル ストゥディオルム−ウニヴェルシタ ディ ボローニャ アルツハイマー病の処置に有用な有機化合物、それらの使用及び調製の方法
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
CA2678577A1 (en) * 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
JP5451611B2 (ja) * 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックインヒビター
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (en) * 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) * 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
JP5730021B2 (ja) * 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤としてのシクロアルキルラクタム誘導体
CA2718264A1 (en) * 2008-03-18 2009-09-24 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
JP5451752B2 (ja) * 2008-05-01 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
BRPI0911764A2 (pt) 2008-05-01 2015-10-06 Boehringer Ingelheim Int inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
PE20110566A1 (es) 2008-07-25 2011-09-02 Boehringer Ingelheim Int Inhibidores ciclicos de 11beta-hidroxiesteroide deshidrogenasa 1
CA2744946A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
GEP20156309B (en) * 2009-04-30 2015-07-10 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
US8883778B2 (en) 2009-07-01 2014-11-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CN103179960A (zh) 2010-11-02 2013-06-26 贝林格尔.英格海姆国际有限公司 治疗代谢疾病的药物组合

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
EP0850222B1 (en) * 1996-06-29 2003-05-28 Samjin Pharmaceutical Co., Ltd. Piperazine derivatives and process for the preparation thereof
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
FR2753706B1 (fr) 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE19743435A1 (de) 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
IL141724A0 (en) 1998-08-28 2002-03-10 Scios Inc INHIBITORS OF P38-α KINASE
WO2000051614A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferases

Also Published As

Publication number Publication date
DE10035927A1 (de) 2002-03-07
PL358808A1 (en) 2004-08-23
WO2002008194A1 (de) 2002-01-31
MXPA02012564A (es) 2003-09-22
SK1932003A3 (en) 2003-10-07
PT1301485E (pt) 2007-08-30
BR0112591A (pt) 2003-07-22
ATE365717T1 (de) 2007-07-15
CA2353360A1 (en) 2002-01-21
JP2004504382A (ja) 2004-02-12
US6706722B2 (en) 2004-03-16
CN1443172A (zh) 2003-09-17
EP1301485A1 (de) 2003-04-16
NO20030301L (no) 2003-03-11
AU2001289675B2 (en) 2005-04-07
DK1301485T3 (da) 2007-11-05
KR20030022296A (ko) 2003-03-15
CN1296359C (zh) 2007-01-24
US20020132821A1 (en) 2002-09-19
AR033383A1 (es) 2003-12-17
NZ524155A (en) 2005-04-29
BG107507A (bg) 2003-09-30
NO324939B1 (no) 2008-01-07
CZ2003427A3 (cs) 2003-06-18
ES2291349T3 (es) 2008-03-01
WO2002008194A8 (de) 2003-05-08
CY1106890T1 (el) 2012-09-26
EP1301485B1 (de) 2007-06-27
HUP0303729A3 (en) 2009-01-28
RU2267488C2 (ru) 2006-01-10
NO20030301D0 (no) 2003-01-20
ZA200210411B (en) 2003-02-26
DE50112669D1 (de) 2007-08-09
AU8967501A (en) 2002-02-05
IL153476A0 (en) 2003-07-06
HUP0303729A2 (hu) 2004-03-01
UA75085C2 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
HK1057549A1 (en) Heteroaryl derivatives and the use thereof as pharmaceuticals
IL153361A0 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
AU2001289675A1 (en) Novel Heteroaryl Derivatives and the Use Thereof as Pharmaceuticals
AU2001279757A1 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
AU8198901A (en) Novel heteroaryl derivatives and use thereof as medicaments
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HUP0202214A2 (en) Adamantane derivatives, preparation and use thereof
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
AP2001002250A0 (en) Pharmaceuticals
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001274535A1 (en) Hydroxyformamidine derivatives and medicines containing the same
IL149993A0 (en) Novel heteroaryl derivatives, their preparation and use
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
SI1301485T1 (sl) Derivati akridina in njihova uporaba kot zdravila
IL156032A0 (en) Spiroindene derivatives and pharmaceutical compositions containing the same
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100718